Real-World Evidence Study of Naltrexone/Bupropion for Achieving Clinically Significant Weight Loss

被引：0
|
作者：
Arora, Mansi
Rajasekharan, Shruti
Rohela, Pallavi
Sandhu, RajanPaul
Naidu, Rishi
Hamm, Caroline
Naidu, Padmaja
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-343
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [1] The real-world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review
    Wharton, Sean
    Kamran, Elham
    Thabane, Lehana
    Yin, Peter
    Christensen, Rebecca
    CLINICAL OBESITY, 2024,
  • [2] Naltrexone and bupropion for weight loss
    Thomas, Betsy
    Lindblad, Adrienne J.
    Luu, Thao
    Paige, Allison
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : E179 - E180
  • [3] Naltrexone-bupropion for weight loss
    Thomas, Betsy
    Lindblad, Adrienne J.
    Luu, Thao
    Paige, Allison
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : 627 - 627
  • [4] Naltrexone/Bupropion (Contrave) for Weight Loss
    Early, Jessica
    Whitten, Jean Suzin
    AMERICAN FAMILY PHYSICIAN, 2015, 91 (08) : 554 - +
  • [5] Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study
    Welling, Mila S.
    de Groot, Cornelis J.
    Mohseni, Mostafa
    Meeusen, Renate E. H.
    Boon, Mariette R.
    van Haelst, Mieke M.
    van den Akker, Erica L. T.
    van Rossum, Elisabeth F. C.
    ECLINICALMEDICINE, 2024, 74
  • [6] ANALYSIS OF COMBINATION OF NALTREXONE WITH BUPROPION FOR WEIGHT LOSS
    Pirzada, Hannah
    Anwar, Saeed
    ul Hasan, Nadeem
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 10275 - 10278
  • [7] Contrave - A Combination of Bupropion and Naltrexone for Weight Loss
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 112 - 114
  • [8] Measuring the Real-World Clinical Efficacy of Naltrexone/Bupropion (NB) for Obesity Management
    Naidu, Padmaja
    Sood, Siddhartha
    OBESITY, 2020, 28 : 123 - 123
  • [9] Naltrexone plus Bupropion Combination Causes Significant Weight Loss: A 56-Week Phase 3 Study
    Wadden, Thomas
    Klein, Samuel
    Greenway, Frank L.
    Erickson, Janelle
    Kim, Dennis D.
    Dunayevich, Eduardo
    Pl-Sunyer, F. Xavier
    DIABETES, 2009, 58 : A10 - A10
  • [10] FACTORS ASSOCIATED WITH ACHIEVING CLINICALLY SIGNIFICANT WEIGHT LOSS IN A NATIONAL, NONPROFIT WEIGHT LOSS PROGRAM
    Mitchell, Nia S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 : S158 - S159
12345